Macquarie Group LTD Bei Gene, Ltd. Transaction History

Macquarie Group LTD

  • $85.1 Billion
  • Q2 2024

A detailed history of Macquarie Group LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Macquarie Group LTD holds 45,719 shares of BGNE stock, worth $9.99 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
45,719
Previous 45,668 0.11%
Holding current value
$9.99 Million
Previous $7.14 Million 8.68%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$129.52 - $174.32 $6,605 - $8,890
51 Added 0.11%
45,719 $6.52 Million
Q1 2024

May 14, 2024
BUY
$141.8 - $181.47 $2.3 Million - $2.95 Million
16,231 Added 55.14%
45,668 $7.14 Million
Q4 2023

Feb 14, 2024
BUY
$158.67 - $201.58 $915,049 - $1.16 Million
5,767 Added 24.36%
29,437 $5.31 Million
Q3 2023

Nov 14, 2023
BUY
$179.87 - $225.13 $453,632 - $567,777
2,522 Added 11.93%
23,670 $4.26 Million
Q2 2023

Aug 14, 2023
SELL
$178.3 - $266.78 $31,202 - $46,686
-175 Reduced 0.82%
21,148 $3.77 Million
Q1 2023

May 15, 2023
SELL
$215.53 - $274.5 $581,931 - $741,150
-2,700 Reduced 11.24%
21,323 $4.6 Million
Q4 2022

Feb 21, 2023
BUY
$125.51 - $229.3 $68,026 - $124,280
542 Added 2.31%
24,023 $5.28 Million
Q3 2022

Nov 14, 2022
BUY
$131.8 - $202.24 $54,038 - $82,918
410 Added 1.78%
23,481 $3.17 Million
Q2 2022

Aug 15, 2022
SELL
$121.11 - $216.05 $1.12 Million - $2 Million
-9,257 Reduced 28.63%
23,071 $3.73 Million
Q1 2022

May 16, 2022
SELL
$146.52 - $269.56 $8.98 Million - $16.5 Million
-61,270 Reduced 65.46%
32,328 $6.1 Million
Q4 2021

Feb 11, 2022
SELL
$248.56 - $389.34 $5.86 Million - $9.18 Million
-23,572 Reduced 20.12%
93,598 $25.4 Million
Q3 2021

Nov 12, 2021
SELL
$249.6 - $403.14 $12 Million - $19.4 Million
-48,176 Reduced 29.14%
117,170 $42.5 Million
Q2 2021

Aug 13, 2021
BUY
$292.75 - $367.01 $41.4 Million - $51.9 Million
141,324 Added 588.31%
165,346 $56.7 Million
Q1 2021

May 14, 2021
SELL
$260.64 - $382.12 $989,389 - $1.45 Million
-3,796 Reduced 13.65%
24,022 $8.36 Million
Q4 2020

Feb 16, 2021
SELL
$221.31 - $316.61 $1 Million - $1.43 Million
-4,530 Reduced 14.0%
27,818 $7.19 Million
Q3 2020

Nov 13, 2020
SELL
$189.18 - $286.44 $587,971 - $890,255
-3,108 Reduced 8.77%
32,348 $9.27 Million
Q2 2020

Aug 11, 2020
SELL
$123.9 - $195.41 $679,467 - $1.07 Million
-5,484 Reduced 13.4%
35,456 $6.68 Million
Q1 2020

May 15, 2020
SELL
$121.84 - $173.19 $598,478 - $850,709
-4,912 Reduced 10.71%
40,940 $5.04 Million
Q4 2019

Feb 14, 2020
SELL
$115.78 - $208.34 $44,227 - $79,585
-382 Reduced 0.83%
45,852 $7.6 Million
Q3 2019

Nov 14, 2019
SELL
$120.61 - $148.29 $7.77 Million - $9.56 Million
-64,442 Reduced 58.23%
46,234 $5.66 Million
Q2 2019

Aug 14, 2019
BUY
$113.99 - $146.86 $406,944 - $524,290
3,570 Added 3.33%
110,676 $13.7 Million
Q1 2019

May 15, 2019
SELL
$122.82 - $151.83 $601,818 - $743,967
-4,900 Reduced 4.37%
107,106 $14.1 Million
Q4 2018

Feb 15, 2019
BUY
$107.01 - $175.15 $96,309 - $157,635
900 Added 0.81%
112,006 $15.7 Million
Q3 2018

Nov 15, 2018
BUY
$152.62 - $189.66 $16.8 Million - $20.9 Million
110,006 Added 10000.55%
111,106 $19.1 Million
Q2 2018

Aug 14, 2018
BUY
$152.5 - $216.77 $30,500 - $43,354
200 Added 22.22%
1,100 $169,000
Q1 2018

May 11, 2018
BUY
$97.41 - $177.22 $87,669 - $159,498
900 New
900 $151,000

Others Institutions Holding BGNE

# of Institutions
213
Shares Held
45.5M
Call Options Held
106K
Put Options Held
93.1K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $22.7B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email